MRSA is uncommon in the neonate
Ampicillin 75mg/kg IV q6hrs PLUS
Cefotaxime 50mg/kg IV q6hrs OR Gentamicin 2.5mg/kg IV q8hrs
Per AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups
If suspecting S. pneumoniae or MRSA, add Vancomycin
Consider acyclovir for HSV
Per AAP, ceftazidime 50mg/kg IV (q12hr for babies < 8 days of age, q8hr for >7 days old) is a reasonable alternative to cefotaxime, offering virtually the same coverage for enteric bacilli and is FDA approved for all age groups
Acyclovir 20 mg/kg IV every 8 hours (duration depends on classification)
If ocular involvement:
1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
Optho consult
As for any febrile neonate SBI evaluation:
Ampicillin + gentamycin
May substitute gentamycin with cefotaxime/ceftazidime
1% trifluridine, 0.1% iododeoxyuridine, or 3% vidarabine
Optho consult
Ampicillin + gentamycin
May substitute gentamycin with cefotaxime/ceftazidime
May substitute gentamycin with cefotaxime/ceftazidime
Pediatric antibiotics
OB/GYN antibiotics
Skin and soft tissue antibiotics
Newborn resuscitation
Post exposure prophylaxis antibiotics
Baby feeding and nutrition
Sepsis antibiotics
Neuro antibiotics